- Investing Ideas
- Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Results
7
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
7 companies
argenx
Market Cap: €45.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€748.60
7D
-3.5%
1Y
28.5%
UCB
Market Cap: €42.6b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€229.20
7D
-8.6%
1Y
25.4%
Celyad Oncology
Market Cap: €11.6m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.25
7D
-8.4%
1Y
-36.9%
Hyloris Pharmaceuticals
Market Cap: €126.3m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.70
7D
0%
1Y
-28.1%
Financière de Tubize
Market Cap: €8.6b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€196.30
7D
-8.3%
1Y
30.7%
Oxurion
Market Cap: €230.6k
A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.
OXUR
€0.0026
7D
0%
1Y
-91.3%
BioSenic
Market Cap: €1.3m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.002
7D
0%
1Y
-20.0%